(PharmaNewsWire.Com, December 21, 2017 ) The Europe Single-use Bioprocessing Market was worth USD 677 million in 2016 and estimated to be growing at a CAGR of 17.6%, to reach USD 1.52 billion by 2021. The market is showing lucrative growth potential in the forecast period and is expected to continue its growth in the years that follow
Single-use bioprocessing technology is a quickly developing technology that concentrates on manufacturing disposable bioprocessing equipment and accessories for producing biopharmaceutical products. Bioprocess utilizes living cells or their components such as enzymes, bacteria, and others to get the required products. The main idea behind the use of single-use bioprocessing technique in the bioprocess is to reduce the cost of complicated steps such as cleaning, sterilization, and maintenance of steel-based bioreactor systems.
Improving R & D activities, rising popularity for disposable biopharmaceuticals, high spending ability of the region and technological development in the bioprocessing systems is driving the growth of Europe single-use bio-processing systems market. However, possible environmental and economic hazards are the major factors constraining the growth of the single use bioprocessing market.
The Europe Single-use Bioprocessing market is broadly categorized on the basis of Product into Media Bags and Containers, Filtration assemblies, Single-use Bioreactors, Disposable Mixers and Others. The media bags and containers segment holds the largest share of the single-use bioprocessing market as of 2016 owing to the growing adoption of media bags and containers in transportation and storage application. Based on Application, the market is segmented as Filtration, Storage, Cell Culture, Mixing and Purification, wherein the filtration segment leads the market due to growing popularity of single-use tangential flow filters, depth filters, and chromatography columns in the process development. Further, by End User the market is classified into Research and Development Institutes and Biopharmaceutical manufacturers.
On the basis of region the Europe market is segmented into Germany, U.K, Denmark, Netherlands, France, Italy, Spain and Rest of Europe. Germany and U.K are the major countries holding large shares of single-use bio-processing systems market in Europe. They are developed countries and will continue to gain momentum in the future years.
The major players dominating the Single-use Bioprocessing market are Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.
About Market Data Forecast: The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
